Single User License
INR 270240
Site License
INR 540480
Corporate User License
INR 810720

Service Tax Additional

select a format
Price

Single User License
USD 4000
Site License
USD 8000
Corporate User License
USD 12000

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


Ophthalmic Imaging Equipment-Medical Devices Pipeline Assessment, 2016

Ophthalmic Imaging Equipment-Medical Devices Pipeline Assessment, 2016


  Request for Sample Report

Executive Summary

Ophthalmic Imaging Equipment-Medical Devices Pipeline Assessment, 2016

Summary

GlobalData's Medical Devices sector report, "Ophthalmic Imaging Equipment-Medical Devices Pipeline Assessment, 2016" provides an overview of Ophthalmic Imaging Equipment currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Ophthalmic Imaging Equipment pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

Extensive coverage of the Ophthalmic Imaging Equipment under development

The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

The report reviews the major players involved in the development of Ophthalmic Imaging Equipment and list all their pipeline projects

The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

The report provides key clinical trial data of ongoing trials specific to pipeline products

Recent developments in the segment / industry

Reasons To Buy

The report enables you to

Formulate significant competitor information, analysis, and insights to improve R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of Ophthalmic Imaging Equipment under development

Develop market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

In-depth analysis of the product's current stage of development, territory and estimated launch date

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 6

1.2 List of Figures 9

2 Introduction 10

2.1 Ophthalmic Imaging Equipment Overview 10

3 Products under Development 11

3.1 Ophthalmic Imaging Equipment-Pipeline Products by Stage of Development 11

3.2 Ophthalmic Imaging Equipment-Pipeline Products by Segment 12

3.3 Ophthalmic Imaging Equipment-Pipeline Products by Territory 13

3.4 Ophthalmic Imaging Equipment-Pipeline Products by Regulatory Path 14

3.5 Ophthalmic Imaging Equipment-Pipeline Products by Estimated Approval Date 15

3.6 Ophthalmic Imaging Equipment-Ongoing Clinical Trials 16

4 Ophthalmic Imaging Equipment-Pipeline Products under Development by Companies 17

4.1 Ophthalmic Imaging Equipment Companies-Pipeline Products by Stage of Development 17

4.2 Ophthalmic Imaging Equipment-Pipeline Products by Stage of Development 19

5 Ophthalmic Imaging Equipment Companies and Product Overview 21

5.1 Aeon Imaging, LLC Company Overview 21

5.1.1 Aeon Imaging, LLC Pipeline Products & Ongoing Clinical Trials Overview 21

5.2 Aeon Scientific AG Company Overview 22

5.2.1 Aeon Scientific AG Pipeline Products & Ongoing Clinical Trials Overview 22

5.3 ArcScan, Inc. Company Overview 23

5.3.1 ArcScan, Inc. Pipeline Products & Ongoing Clinical Trials Overview 23

5.4 Ben-Gurion University of the Negev Company Overview 26

5.4.1 Ben-Gurion University of the Negev Pipeline Products & Ongoing Clinical Trials Overview 26

5.5 Brien Holden Vision Institute Company Overview 27

5.5.1 Brien Holden Vision Institute Pipeline Products & Ongoing Clinical Trials Overview 27

5.6 CW Optics, Inc. Company Overview 28

5.6.1 CW Optics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 28

5.7 Dalhousie University Company Overview 29

5.7.1 Dalhousie University Pipeline Products & Ongoing Clinical Trials Overview 29

5.8 Exploit Technologies Pte Ltd Company Overview 30

5.8.1 Exploit Technologies Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 30

5.9 Eye Marker Systems, Inc. Company Overview 31

5.9.1 Eye Marker Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 31

5.10 Eye Tech Care SA Company Overview 32

5.10.1 Eye Tech Care SA Pipeline Products & Ongoing Clinical Trials Overview 32

5.11 Gemss Co.,Ltd. Company Overview 35

5.11.1 Gemss Co.,Ltd. Pipeline Products & Ongoing Clinical Trials Overview 35

5.12 George Washington University Company Overview 36

5.12.1 George Washington University Pipeline Products & Ongoing Clinical Trials Overview 36

5.13 Massachusetts Eye and Ear Infirmary Company Overview 37

5.13.1 Massachusetts Eye and Ear Infirmary Pipeline Products & Ongoing Clinical Trials Overview 37

5.14 Moorfields Eye Hospital NHS Foundation Trust Company Overview 38

5.14.1 Moorfields Eye Hospital NHS Foundation Trust Pipeline Products & Ongoing Clinical Trials Overview 38

5.15 Next Dimension Ltd. Company Overview 41

5.15.1 Next Dimension Ltd. Pipeline Products & Ongoing Clinical Trials Overview 41

5.16 OcuSciences, Inc. Company Overview 42

5.16.1 OcuSciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 42

5.17 Ocutronics, LLC Company Overview 43

5.17.1 Ocutronics, LLC Pipeline Products & Ongoing Clinical Trials Overview 43

5.18 Ohio State University Company Overview 44

5.18.1 Ohio State University Pipeline Products & Ongoing Clinical Trials Overview 44

5.19 Optos Plc Company Overview 45

5.19.1 Optos Plc Pipeline Products & Ongoing Clinical Trials Overview 45

5.20 PCAsso Diagnostics LLC Company Overview 50

5.20.1 PCAsso Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 50

5.21 Praevium Research Inc. Company Overview 51

5.21.1 Praevium Research Inc. Pipeline Products & Ongoing Clinical Trials Overview 51

5.22 Predictek, Inc. Company Overview 52

5.22.1 Predictek, Inc. Pipeline Products & Ongoing Clinical Trials Overview 52

5.23 Rensselaer Polytechnic Institute Company Overview 53

5.23.1 Rensselaer Polytechnic Institute Pipeline Products & Ongoing Clinical Trials Overview 53

5.24 RetiVue, LLC Company Overview 54

5.24.1 RetiVue, LLC Pipeline Products & Ongoing Clinical Trials Overview 54

5.25 Ti-TaMed (PTY) LTD. Company Overview 55

5.25.1 Ti-TaMed (PTY) LTD. Pipeline Products & Ongoing Clinical Trials Overview 55

5.26 Tufts University Company Overview 56

5.26.1 Tufts University Pipeline Products & Ongoing Clinical Trials Overview 56

5.27 Universite de Montreal Company Overview 57

5.27.1 Universite de Montreal Pipeline Products & Ongoing Clinical Trials Overview 57

5.28 University College London Company Overview 59

5.28.1 University College London Pipeline Products & Ongoing Clinical Trials Overview 59

5.29 University of Arizona Company Overview 61

5.29.1 University of Arizona Pipeline Products & Ongoing Clinical Trials Overview 61

5.30 University of California, Los Angeles Company Overview 62

5.30.1 University of California, Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 62

5.31 University of Colorado Company Overview 64

5.31.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 64

5.32 University of South Florida Company Overview 65

5.32.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 65

5.33 University of Valencia Company Overview 66

5.33.1 University of Valencia Pipeline Products & Ongoing Clinical Trials Overview 66

5.34 Vision Instruments Pty. Ltd. Company Overview 67

5.34.1 Vision Instruments Pty. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 67

5.35 VisionQuest Biomedical, LLC Company Overview 68

5.35.1 VisionQuest Biomedical, LLC Pipeline Products & Ongoing Clinical Trials Overview 68

5.36 Visual Pathways, Inc. (Inactive) Company Overview 73

5.36.1 Visual Pathways, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 73

6 Ophthalmic Imaging Equipment- Recent Developments 76

6.1 Nov 07, 2016: Molecular Partners Announces Management Change 76

6.2 Nov 02, 2016: NOVADAQ Reports Third Quarter 2016 Financial Results 76

6.3 Oct 27, 2016: Molecular Partners: Quarterly Management Statement For The Period Ending September 30, 2016 77

6.4 Oct 27, 2016: ContextVision Presents Q3 2016 Financial Report 79

6.5 Oct 13, 2016: Carl Zeiss Meditec appoints Steven C. Schallhorn, MD as Chief Medical Officer 80

6.6 Oct 11, 2016: DigiSight Technologies Showcases State-of-the-Art Paxos Scope Mobile Imaging Solution At AAO 2016 81

6.7 Sep 28, 2016: Hill-Rom Adding More Than 100 Jobs In Central New York 81

6.8 Sep 12, 2016: Canon U.S.A. to Display Eyecare Devices and Solutions at Vision Expo West 82

6.9 Sep 09, 2016: KKR Invests USD66 Million in AcuFocus 83

6.10 Sep 01, 2016: Molecular Partners reports unaudited half-year results for 2016: A period of continued progress for Molecular Partners 83

6.11 Aug 18, 2016: ContextVision presents Q2 2016 financial report 85

6.12 Aug 12, 2016: Carl Zeiss Meditec Grows in Ophthalmology and Microsurgery 86

6.13 Aug 08, 2016: TearScience Names Edward J. Holland, MD to Board of Directors 87

6.14 Aug 02, 2016: MCW Researchers Lead Imaging Study of Patients with Genetic Color Vision Disorder in Advance of AGTC Gene Therapy Clinical Trials 88

6.15 Jul 27, 2016: NOVADAQ Reports Second Quarter 2016 Financial Results 88

6.16 Jul 27, 2016: Carl Zeiss Meditec Recruits James V. Mazzo to Lead Its Newly Consolidated Ophthalmology Organization 89

6.17 Jul 20, 2016: Carl Zeiss Meditec announces change to Management Board 90

6.18 Jul 13, 2016: CoxHealth brings diabetic digital retinal imaging to its patients 90

6.19 Jul 06, 2016: Natus Medical Acquires RetCam Ophthalmic Imaging Systems from Clarity Medical Systems for USD10.6 Million 90

6.20 Jul 06, 2016: NOVADAQ Announces Appointment of Rick Mangat as President and CEO 90

6.21 Jun 24, 2016: AcuFocus Raises USD1.9 Million in Venture Financing 91

6.22 May 16, 2016: Escalon Medical Reports Third Quarter Fiscal 2016 Results 91

6.23 May 11, 2016: Carl Zeiss Meditec Records Revenue Growth of 8.6 Percent 92

6.24 May 11, 2016: Nephros Reports First Quarter 2016 Financial Results 93

6.25 May 05, 2016: TearScience Introduces LipiScan For Rapid High Definition Meibomian Imaging 94

6.26 May 02, 2016: Large UK National Health Services (NHS) Study Finds EyeArt Device To Be the Most Sensitive Automated Retinal Image Analysis Technology for Diabetic Retinopathy Screening 94

6.27 Apr 29, 2016: Bausch + Lomb Highlights Scientific and Clinical Research during the Association for Research in Vision and Ophthalmology Annual Meeting in Seattle, WA 95

6.28 Apr 28, 2016: Quarterly Management Statement For The Period Ending March 31, 2016 96

6.29 Apr 14, 2016: ArcScan receives CE Mark Approval for Its Insight 100 device enabling commercialization across Europe 98

6.30 Apr 13, 2016: Molecular Partners Raises USD31.7 Million in Private Placement of Shares 98

6.31 Apr 12, 2016: iSTAR Medical Raises USD11.4 Million in Series B Financing 99

6.32 Mar 22, 2016: Breakthrough Handheld Technology from Welch Allyn Makes Diabetic Retinopathy Screening Simple and Affordable for Primary Care Settings 99

6.33 Mar 17, 2016: AcuFocus Raises USD4 Million in Financing 99

6.34 Feb 29, 2016: Canon U.S.A. Showcases Solutions and Services that can Help Healthcare Providers Achieve a More Complete EHR Strategy at HIMSS 2016 100

6.35 Feb 16, 2016: Escalon Medical Reports Second Quarter Fiscal 2016 Results 101

6.36 Feb 04, 2016: Molecular Partners reports unaudited financial results for 2015 101

6.37 Jan 25, 2016: AstraZeneca partners with peers and academia to establish translational research fund 104

6.38 Jan 24, 2016: Fallas Family Vision of McDonough, Georgia, Adds OptoMap Retinal System for an Ultra-Wide View of the Retina During Eye Exams 105

6.39 Jan 15, 2016: Remidio Innovative Solutions Raises Funds in Series B Financing 106

6.40 Jan 11, 2016: Bausch + Lomb Announces 2016 Elite Vendor Relationship with Vision Source 106

6.41 Dec 10, 2015: Molecular Partners received a European Small and Mid-Cap Award 106

6.42 Dec 03, 2015: ArcScan Finalizes US Food and Drug Administration Submission for Its Insight 100 Ophthalmic Medical Device 107

7 Appendix 108

7.1 Methodology 108

7.2 About GlobalData 111

7.3 Contact Us 111

7.4 Disclaimer 111

1.2 List of Figures

Figure 1: Ophthalmic Imaging Equipment-Pipeline Products by Stage of Development 11

Figure 2: Ophthalmic Imaging Equipment-Pipeline Products by Segment 12

Figure 3: Ophthalmic Imaging Equipment-Pipeline Products by Territory 13

Figure 4: Ophthalmic Imaging Equipment-Pipeline Products by Regulatory Path 14

Figure 5: Ophthalmic Imaging Equipment-Pipeline Products by Estimated Approval Date 15

Figure 6: Ophthalmic Imaging Equipment-Ongoing Clinical Trials 16

1.1 List of Tables

Table 1: Ophthalmic Imaging Equipment-Pipeline Products by Stage of Development 11

Table 2: Ophthalmic Imaging Equipment-Pipeline Products by Segment 12

Table 3: Ophthalmic Imaging Equipment-Pipeline Products by Territory 13

Table 4: Ophthalmic Imaging Equipment-Pipeline Products by Regulatory Path 14

Table 5: Ophthalmic Imaging Equipment-Pipeline Products by Estimated Approval Date 15

Table 6: Ophthalmic Imaging Equipment-Ongoing Clinical Trials 16

Table 7: Ophthalmic Imaging Equipment Companies-Pipeline Products by Stage of Development 17

Table 8: Ophthalmic Imaging Equipment-Pipeline Products by Stage of Development 19

Table 9: Aeon Imaging, LLC Pipeline Products & Ongoing Clinical Trials Overview 21

Table 10: DLP-Cam-Product Status 21

Table 11: DLP-Cam-Product Description 21

Table 12: Aeon Scientific AG Pipeline Products & Ongoing Clinical Trials Overview 22

Table 13: OctoMag System-Product Status 22

Table 14: OctoMag System-Product Description 22

Table 15: ArcScan, Inc. Pipeline Products & Ongoing Clinical Trials Overview 23

Table 16: Artemis 3-Product Status 23

Table 17: Artemis 3-Product Description 23

Table 18: ArcScan, Inc.-Ongoing Clinical Trials Overview 24

Table 19: Artemis 3-Early Detection of Keratoconus 25

Table 20: Ben-Gurion University of the Negev Pipeline Products & Ongoing Clinical Trials Overview 26

Table 21: Diagnostic Tool-Retinal Disorders-Product Status 26

Table 22: Diagnostic Tool-Retinal Disorders-Product Description 26

Table 23: Brien Holden Vision Institute Pipeline Products & Ongoing Clinical Trials Overview 27

Table 24: Advanced Retinal Imaging System-Product Status 27

Table 25: Advanced Retinal Imaging System-Product Description 27

Table 26: CW Optics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 28

Table 27: RetinalImager-Product Status 28

Table 28: RetinalImager-Product Description 28

Table 29: Dalhousie University Pipeline Products & Ongoing Clinical Trials Overview 29

Table 30: Eye Imaging Device-Product Status 29

Table 31: Eye Imaging Device-Product Description 29

Table 32: Exploit Technologies Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 30

Table 33: Ocular Surface Disease Diagnostic System-Product Status 30

Table 34: Ocular Surface Disease Diagnostic System-Product Description 30

Table 35: Eye Marker Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 31

Table 36: RTD 1000-Product Status 31

Table 37: RTD 1000-Product Description 31

Table 38: Eye Tech Care SA Pipeline Products & Ongoing Clinical Trials Overview 32

Table 39: EyeOP1-Product Status 32

Table 40: EyeOP1-Product Description 32

Table 41: Eye Tech Care SA-Ongoing Clinical Trials Overview 33

Table 42: EyeOP1-EYEOP1, A Minimally-invasive, Single Use Ultrasound System Intended To Treat Refractory Glaucoma 34

Table 43: EyeOP1-EYEOP1, A Minimally-invasive, Single Use Ultrasound System Intended To Treat Refractory Glaucoma 34

Table 44: EyeOP1-Glaucoma Treatment Using Focused Ultrasound in Open Angle Glaucoma Patients 34

Table 45: Gemss Co.,Ltd. Pipeline Products & Ongoing Clinical Trials Overview 35

Table 46: Motorized C-arm System-Product Status 35

Table 47: Motorized C-arm System-Product Description 35

Table 48: George Washington University Pipeline Products & Ongoing Clinical Trials Overview 36

Table 49: iEye-Product Status 36

Table 50: iEye-Product Description 36

Table 51: Massachusetts Eye and Ear Infirmary Pipeline Products & Ongoing Clinical Trials Overview 37

Table 52: Portable Mydriatic Cameras-Product Status 37

Table 53: Portable Mydriatic Cameras-Product Description 37

Table 54: Moorfields Eye Hospital NHS Foundation Trust Pipeline Products & Ongoing Clinical Trials Overview 38

Table 55: Binocular Optical Coherence Tomography-Product Status 38

Table 56: Binocular Optical Coherence Tomography-Product Description 38

Table 57: Moorfields Eye Hospital NHS Foundation Trust-Ongoing Clinical Trials Overview 39

Table 58: Binocular Optical Coherence Tomography-A Prospective Single-Site Non-Interventional Study to Evaluate Human Factors and Usability of Automated, Comprehensive Ocular Examination in Elderly and Visually Impaired Populations Using a Prototype Binocular Optical Coherence Tomography System 40

Table 59: Next Dimension Ltd. Pipeline Products & Ongoing Clinical Trials Overview 41

Table 60: Retinal Spectral Imaging System-Product Status 41

Table 61: Retinal Spectral Imaging System-Product Description 41

Table 62: OcuSciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 42

Table 63: OcuMet Beacon-Product Status 42

Table 64: OcuMet Beacon-Product Description 42

Table 65: Ocutronics, LLC Pipeline Products & Ongoing Clinical Trials Overview 43

Table 66: Ocutronics OC-100 Retinal Camera-Product Status 43

Table 67: Ocutronics OC-100 Retinal Camera-Product Description 43

Table 68: Ohio State University Pipeline Products & Ongoing Clinical Trials Overview 44

Table 69: Interferometric Imaging System-Product Status 44

Table 70: Interferometric Imaging System-Product Description 44

Table 71: Optos Plc Pipeline Products & Ongoing Clinical Trials Overview 45

Table 72: 200TX Replacement Device-Product Status 45

Table 73: 200TX Replacement Device-Product Description 46

Table 74: CHARLOTTE-Product Status 46

Table 75: CHARLOTTE-Product Description 46

Table 76: INDIANAPOLIS-Product Status 47

Table 77: INDIANAPOLIS-Product Description 47

Table 78: Optos Plc-Ongoing Clinical Trials Overview 48

Table 79: 200TX Replacement Device-A Randomized Trial of Non-mydriatic Ultra-widefield Retinal Imaging to Screen for Diabetic Eye Disease: CLEAR SIGHT 49

Table 80: PCAsso Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 50

Table 81: PolyChromatic Angiography Device-Product Status 50

Table 82: PolyChromatic Angiography Device-Product Description 50

Table 83: Praevium Research Inc. Pipeline Products & Ongoing Clinical Trials Overview 51

Table 84: VCSEL Based OCT System-Product Status 51

Table 85: VCSEL Based OCT System-Product Description 51

Table 86: Predictek, Inc. Pipeline Products & Ongoing Clinical Trials Overview 52

Table 87: IRis-Product Status 52

Table 88: IRis-Product Description 52

Table 89: Rensselaer Polytechnic Institute Pipeline Products & Ongoing Clinical Trials Overview 53

Table 90: Video Scheimpflug Camera-Product Status 53

Table 91: Video Scheimpflug Camera-Product Description 53

Table 92: RetiVue, LLC Pipeline Products & Ongoing Clinical Trials Overview 54

Table 93: CAVCAM-Product Status 54

Table 94: CAVCAM-Product Description 54

Table 95: Ti-TaMed (PTY) LTD. Pipeline Products & Ongoing Clinical Trials Overview 55

Table 96: Optical Device-Product Status 55

Table 97: Optical Device-Product Description 55

Table 98: Tufts University Pipeline Products & Ongoing Clinical Trials Overview 56

Table 99: Digital Single Lens Reflex Adaptor-Product Status 56

Table 100: Digital Single Lens Reflex Adaptor-Product Description 56

Table 101: Universite de Montreal Pipeline Products & Ongoing Clinical Trials Overview 57

Table 102: Diagnostic Software-Ocular Rigidity-Product Status 57

Table 103: Diagnostic Software-Ocular Rigidity-Product Description 58

Table 104: University College London Pipeline Products & Ongoing Clinical Trials Overview 59

Table 105: Ocular Imaging System-Product Status 59

Table 106: Ocular Imaging System-Product Description 60

Table 107: University of Arizona Pipeline Products & Ongoing Clinical Trials Overview 61

Table 108: Retinal Illumination System-Product Status 61

Table 109: Retinal Illumination System-Product Description 61

Table 110: University of California, Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 62

Table 111: Corneal Hydration Sensing System-Product Status 62

Table 112: Corneal Hydration Sensing System-Product Description 63

Table 113: University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 64

Table 114: Multi-Photon Optics Device-Product Status 64

Table 115: Multi-Photon Optics Device-Product Description 64

Table 116: University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 65

Table 117: Adaptive Optics Ophthalmic Imager-Product Status 65

Table 118: Adaptive Optics Ophthalmic Imager-Product Description 65

Table 119: University of Valencia Pipeline Products & Ongoing Clinical Trials Overview 66

Table 120: 3D Imaging Retinal Camera-Product Status 66

Table 121: 3D Imaging Retinal Camera-Product Description 66

Table 122: Vision Instruments Pty. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 67

Table 123: ViNM1 Retinal Camera-Product Status 67

Table 124: ViNM1 Retinal Camera-Product Description 67

Table 125: VisionQuest Biomedical, LLC Pipeline Products & Ongoing Clinical Trials Overview 68

Table 126: DR-RACS-Product Status 68

Table 127: DR-RACS-Product Description 69

Table 128: Functional Scanning Laser Ophthalmoscope-Product Status 69

Table 129: Functional Scanning Laser Ophthalmoscope-Product Description 70

Table 130: VisionQuest Biomedical, LLC-Ongoing Clinical Trials Overview 71

Table 131: DR-RACS-Phase 0 Observational Study of a Computer-based Screening Algorithm for Detection of Diabetic Retinopathy 72

Table 132: Visual Pathways, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 73

Table 133: Aris HySpect-Product Status 73

Table 134: Aris HySpect-Product Description 73

Table 135: Aris Pixie-Product Status 74

Table 136: Aris Pixie-Product Description 74

Table 137: ArisWareEP-3D-Product Status 74

Table 138: ArisWareEP-3D-Product Description 75

Table 139: Glossary 109

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Aeon Imaging, LLC, Aeon Scientific AG, ArcScan, Inc., Ben-Gurion University of the Negev, Brien Holden Vision Institute, CW Optics, Inc., Dalhousie University, Exploit Technologies Pte Ltd, Eye Marker Systems, Inc., Eye Tech Care SA, Gemss Co.,Ltd., George Washington University, Massachusetts Eye and Ear Infirmary, Moorfields Eye Hospital NHS Foundation Trust, Next Dimension Ltd., OcuSciences, Inc., Ocutronics, LLC, Ohio State University, Optos Plc, PCAsso Diagnostics LLC, Praevium Research Inc., Predictek, Inc., Rensselaer Polytechnic Institute, RetiVue, LLC, Ti-TaMed (PTY) LTD., Tufts University, Universite de Montreal, University College London, University of Arizona, University of California, Los Angeles, University of Colorado, University of South Florida, University of Valencia, Vision Instruments Pty. Ltd., VisionQuest Biomedical, LLC, Visual Pathways, Inc.

Aeon Imaging, LLC, DLP-Cam; Aeon Scientific AG, OctoMag System; ArcScan, Inc., Artemis 3; Ben-Gurion University of the Negev, Diagnostic Tool-Retinal Disorders; Brien Holden Vision Institute, Advanced Retinal Imaging System; CW Optics, Inc., RetinalImager; Dalhousie University, Eye Imaging Device; Exploit Technologies Pte Ltd, Ocular Surface Disease Diagnostic System; Eye Marker Systems, Inc., RTD 1000; Eye Tech Care SA, EyeOP1; Gemss Co.,Ltd., Motorized C-arm System; George Washington University, iEye; Massachusetts Eye and Ear Infirmary, Portable Mydriatic Cameras; Moorfields Eye Hospital NHS Foundation Trust, Binocular Optical Coherence Tomography; Next Dimension Ltd., Retinal Spectral Imaging System; OcuSciences, Inc., OcuMet Beacon; Ocutronics, LLC, Ocutronics OC-100 Retinal Camera; Ohio State University, Interferometric Imaging System; Optos Plc, 200TX Replacement Device; CHARLOTTE; INDIANAPOLIS; PCAsso Diagnostics LLC, PolyChromatic Angiography Device; Praevium Research Inc., VCSEL Based OCT System; Predictek, Inc., IRis; Rensselaer Polytechnic Institute, Video Scheimpflug Camera; RetiVue, LLC, CAVCAM; Ti-TaMed (PTY) LTD., Optical Device; Tufts University, Digital Single Lens Reflex Adaptor; Universite de Montreal, Diagnostic Software-Ocular Rigidity; University College London, Ocular Imaging System; University of Arizona, Retinal Illumination System; University of California, Los Angeles, Corneal Hydration Sensing System; University of Colorado, Multi-Photon Optics Device; University of South Florida, Adaptive Optics Ophthalmic Imager; University of Valencia, 3D Imaging Retinal Camera; Vision Instruments Pty. Ltd., ViNM1 Retinal Camera; VisionQuest Biomedical, LLC, DR-RACS; VisionQuest Biomedical, LLC, Functional Scanning Laser Ophthalmoscope; Visual Pathways, Inc., Aris HySpect; Aris Pixie; ArisWareEP-3D


Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com